For subscribers
New drug to fight eczema
Dupilumab, approved for use here recently, has been shown to be effective, but is costly
Sign up now: Get ST's newsletters delivered to your inbox
Biologic drug Dupilumab, which is given by injection, reduces inflammation, soothing skin redness, itch and rash associated with eczema.
PHOTO: ISTOCKPHOTO
A newly approved first-of-its-kind biologic drug may give hope to patients who are having a hard time bringing their moderate to severe atopic eczema under control.
Some patients at both public and private institutions, including adolescents, have been treated with the newly available Dupilumab, sold under the brand name Dupixent, which has been shown to be relatively safe and effective in international trials that included Singapore. The Health Sciences Authority approved its use in adult patients about two months ago.
